Abstract:The intravenous infusion of methylene blue was investigated as a procedure that would identify parathyroid glands during operation in 17 patients with primary hyperparathyroidism. The dye was found to stain all adenomas, most hyperplastic glands and occasionally normal parathyrodi glands. In addition, the frequency of glandular staining was directly related to the size of the gland, although size and histology may have been independent variables. Methylene blue infusion is a safe effective method of localizing… Show more
“…There are no prospective studies published on this topic. Many retrospective studies describe its use [90][91][92][93][94][95][96][97][98][99][100][101][102][103], five of them originating from the same center [104][105][106][107][108]. Two of them showed a small but significant reduction in the duration of surgery [107,109].…”
Section: Role Of Methylene Blue Dye Infusionmentioning
Literature review provides the basis for clear recommendations on the use of intraoperative PTH at surgery for PHPT. There is little evidence to support the use of RGP, MB, routine frozen section, and intraoperative neuromonitoring.
“…There are no prospective studies published on this topic. Many retrospective studies describe its use [90][91][92][93][94][95][96][97][98][99][100][101][102][103], five of them originating from the same center [104][105][106][107][108]. Two of them showed a small but significant reduction in the duration of surgery [107,109].…”
Section: Role Of Methylene Blue Dye Infusionmentioning
Literature review provides the basis for clear recommendations on the use of intraoperative PTH at surgery for PHPT. There is little evidence to support the use of RGP, MB, routine frozen section, and intraoperative neuromonitoring.
“…In vitro experiments also show that intravenous doses of MB inhibit monoamine oxidase (MAOI) [7] and may have direct hippocampal neuronal toxicity in rats [5]. The use of MB greatly aids visualization of the parathyroid glands during parathyroidectomy and is given as a preoperative infusion of 5-10 mg/ kg over 45-60 min [1,2,[8][9][10]. After intravenous infusion, it is rapidly accumulated in the parathyroid glands, and animal studies demonstrate rapid CNS accumulation after intravenous administration [11].…”
Section: Discussionmentioning
confidence: 97%
“…Methylene blue (MB) infusion allows direct visualization intraoperatively of the parathyroid glands during parathyroidectomy and is generally safe [1,2]. However, recent reports suggest neurological toxicity and post-operative altered mental state with an uncertain mechanism [3][4][5].…”
Methylene blue, when used in patients on antidepressant drugs, may be associated with a transient encephalopathic state and serotonin syndrome. Patients on antidepressants undergoing parathyroidectomy who may receive MB infusion should be considered for alternative parathyroid gland identification or discontinuation of the antidepressants before surgery. MB-associated serotonin syndrome is an increasing and under recognized ('green') post-operative encephalopathy that warrants education to critical care neurologists and other physicians.
“…MB + is characterised by a low toxicity and high tumour specificity [17][18][19]. As an important vital dye, it can be used for intraoperative in vivo staining of different tumours [20,21]. As a redox indicator, MB + is rapidly reduced to stainless MBH, which is not photodynamically active when given to the organism intravenously [22].…”
Intra-tumoral MB+ PDT is a potential treatment for inducing necrosis in vivo. With regard to tumour tissue, the selectivity of MB+ is high and depends on a precise local injection of the dye.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.